Company Details
Xention
Iconix Park, London Road, Pampisford, Cambridgeshire, CB22 3EG, United Kingdom
Overview
Xention discovers and develops ion channel‑modulating drugs. Its lead development focus is on novel therapies for atrial fibrillation, with plans to advance to clinical proof of concept. The company also has drug candidates targeting overactive bladder and autoimmune disease. Xention recently completed an £8m Series D financing. The funding will support progression of its clinical programs. The company is headquartered in Cambridge, UK.
- Total raised
- $13M
- Funding rounds
- 1
- Latest round
- Series D
- Latest activity
- Nov 2010
Industries
- Biotechnology
- Developer Platform
- Medical
Recent funding
Series D
Nov 2010
$13M
Team
No current team members are available.